Applied Therapeutics Stock Performance
| APLT Stock | USD 0.10 0 4.71% |
The firm shows a Beta (market volatility) of 1.9, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Applied Therapeutics will likely underperform. At this point, Applied Therapeutics has a negative expected return of -1.98%. Please make sure to confirm Applied Therapeutics' information ratio, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Applied Therapeutics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Applied Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
1 | Applied Therapeutics Announces Earnings Results | 11/14/2025 |
2 | Is Applied Therapeutics Inc. stock a top pick for value investors - July 2025 Selloffs Risk Managed Investment Signals - newser.com | 11/18/2025 |
3 | Applied Therapeutics stock rating downgraded by Leerink Partners on cash concerns - Investing.com Nigeria | 12/03/2025 |
4 | SP 500 Down 1 Broadcom Earnings Top Views | 12/12/2025 |
5 | Heres Why Applied Therapeutics Is a Great Buy the Bottom Stock Now | 12/16/2025 |
6 | Acquisition by Les Funtleyder of 150000 shares of Applied Therapeutics subject to Rule 16b-3 | 12/31/2025 |
7 | Applied Therapeutics Upgraded to Buy Heres Why - MSN | 01/06/2026 |
8 | APLT Stock Price, Forecast Analysis APPLIED THERAPEUTICS INC - Chartmill | 01/16/2026 |
9 | Disposition of 965 shares by Adam Hansard of Applied Therapeutics at 1.97 subject to Rule 16b-3 | 01/27/2026 |
10 | Disposition of 23941 shares by Lerner Teena of Applied Therapeutics at 4.7 subject to Rule 16b-3 | 02/03/2026 |
Applied Therapeutics Relative Risk vs. Return Landscape
If you would invest 75.00 in Applied Therapeutics on November 6, 2025 and sell it today you would lose (65.00) from holding Applied Therapeutics or give up 86.67% of portfolio value over 90 days. Applied Therapeutics is currently does not generate positive expected returns and assumes 12.7363% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Applied, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Applied Therapeutics Target Price Odds to finish over Current Price
The tendency of Applied Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.10 | 90 days | 0.10 | about 72.37 |
Based on a normal probability distribution, the odds of Applied Therapeutics to move above the current price in 90 days from now is about 72.37 (This Applied Therapeutics probability density function shows the probability of Applied Stock to fall within a particular range of prices over 90 days) .
Applied Therapeutics Price Density |
| Price |
Predictive Modules for Applied Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Applied Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Applied Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Applied Therapeutics is not an exception. The market had few large corrections towards the Applied Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Applied Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Applied Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -2.63 | |
β | Beta against Dow Jones | 1.90 | |
σ | Overall volatility | 0.32 | |
Ir | Information ratio | -0.21 |
Applied Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Applied Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Applied Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Applied Therapeutics generated a negative expected return over the last 90 days | |
| Applied Therapeutics has high historical volatility and very poor performance | |
| Applied Therapeutics has some characteristics of a very speculative penny stock | |
| Applied Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 455 K. Net Loss for the year was (105.62 M) with loss before overhead, payroll, taxes, and interest of (38.06 M). | |
| Applied Therapeutics currently holds about 67.72 M in cash with (84.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.41, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Applied Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 69.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Disposition of 23941 shares by Lerner Teena of Applied Therapeutics at 4.7 subject to Rule 16b-3 |
Applied Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Applied Stock often depends not only on the future outlook of the current and potential Applied Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Applied Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 139.5 M | |
| Cash And Short Term Investments | 79.4 M |
Applied Therapeutics Fundamentals Growth
Applied Stock prices reflect investors' perceptions of the future prospects and financial health of Applied Therapeutics, and Applied Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Applied Stock performance.
| Return On Equity | -6.8 | ||||
| Return On Asset | -0.88 | ||||
| Operating Margin | (17.97) % | ||||
| Current Valuation | 5.42 M | ||||
| Shares Outstanding | 144.3 M | ||||
| Price To Earning | (7.46) X | ||||
| Price To Book | 7.72 X | ||||
| Price To Sales | 14.86 X | ||||
| Revenue | 455 K | ||||
| Gross Profit | (38.06 M) | ||||
| EBITDA | (104.3 M) | ||||
| Net Income | (105.62 M) | ||||
| Cash And Equivalents | 67.72 M | ||||
| Cash Per Share | 1.41 X | ||||
| Total Debt | 2.79 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 1.49 X | ||||
| Book Value Per Share | (0) X | ||||
| Cash Flow From Operations | (84.31 M) | ||||
| Earnings Per Share | (0.10) X | ||||
| Market Capitalization | 14.86 M | ||||
| Total Asset | 86.69 M | ||||
| Retained Earnings | (574.21 M) | ||||
| Working Capital | 56.35 M | ||||
| Current Asset | 37.74 M | ||||
| Current Liabilities | 11.19 M | ||||
About Applied Therapeutics Performance
Assessing Applied Therapeutics' fundamental ratios provides investors with valuable insights into Applied Therapeutics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Applied Therapeutics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 20.01 | 17.78 | |
| Return On Tangible Assets | (1.40) | (1.47) | |
| Return On Capital Employed | (2.02) | (2.12) | |
| Return On Assets | (1.40) | (1.47) | |
| Return On Equity | (2.13) | (2.24) |
Things to note about Applied Therapeutics performance evaluation
Checking the ongoing alerts about Applied Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Applied Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Applied Therapeutics generated a negative expected return over the last 90 days | |
| Applied Therapeutics has high historical volatility and very poor performance | |
| Applied Therapeutics has some characteristics of a very speculative penny stock | |
| Applied Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 455 K. Net Loss for the year was (105.62 M) with loss before overhead, payroll, taxes, and interest of (38.06 M). | |
| Applied Therapeutics currently holds about 67.72 M in cash with (84.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.41, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Applied Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 69.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Disposition of 23941 shares by Lerner Teena of Applied Therapeutics at 4.7 subject to Rule 16b-3 |
- Analyzing Applied Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Applied Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Applied Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Applied Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Applied Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Applied Therapeutics' stock. These opinions can provide insight into Applied Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.